SEC Form 3
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
| OMB APPROVAL |
| OMB Number: |
3235-0104 |
| Estimated average burden |
| hours per response: |
0.5 |
|
|
1. Name and Address of Reporting Person*| TC Group Cayman Investment Holdings, L.P. |
| C/O WALKERS CORPORATE LIMITED |
| 190 ELGIN AVENUE |
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 01/16/2026
|
3. Issuer Name and Ticker or Trading Symbol
Medline Inc.
[ MDLN ]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
5. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Form filed by One Reporting Person |
| X |
Form filed by More than One Reporting Person |
|
| Table I - Non-Derivative Securities Beneficially Owned |
| 1. Title of Security (Instr.
4)
|
2.
Amount of Securities Beneficially Owned (Instr.
4)
|
3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
4. Nature of Indirect Beneficial Ownership (Instr.
5)
|
| Class A Common Stock |
111,994,953 |
I |
See footnotes
|
|
Class B Common Stock
|
55,557,381 |
I |
See footnotes
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
| 1. Title of Derivative Security (Instr.
4)
|
2. Date Exercisable and Expiration Date
(Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
6. Nature of Indirect Beneficial Ownership (Instr.
5)
|
| Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
| Common Units of Medline Holdings, LP |
|
|
Class A Common Stock |
55,557,381 |
|
I |
See footnotes
|
1. Name and Address of Reporting Person*| TC Group Cayman Investment Holdings, L.P. |
| C/O WALKERS CORPORATE LIMITED |
| 190 ELGIN AVENUE |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*| Carlyle Holdings II GP L.L.C. |
| C/O THE CARLYLE GROUP INC. |
| 1001 PENNSYLVANIA AVE. NW SUITE 220 S |
(Street)
| WASHINGTON, |
DC |
20004-2505 |
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*| Carlyle Holdings II L.L.C. |
| C/O THE CARLYLE GROUP INC. |
| 1001 PENNSYLVANIA AVE. NW SUITE 220 S |
(Street)
| WASHINGTON, |
DC |
20004-2505 |
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*| TC Group Cayman Investment Holdings Sub L.P. |
| C/O WALKERS CORPORATE LIMITED |
| 190 ELGIN AVENUE, |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
| C/O THE CARLYLE GROUP INC. |
| 1001 PENNSYLVANIA AVE. NW SUITE 220 S |
(Street)
| WASHINGTON, |
DC |
20004-2505 |
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
| C/O THE CARLYLE GROUP INC. |
| 1001 PENNSYLVANIA AVE. NW SUITE 220 S |
(Street)
| WASHINGTON, |
DC |
20004-2505 |
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
| Explanation of Responses: |
| Remarks: |
|
TC Group Cayman Investment Holdings, L.P., By: CG Subsidiary Holdings L.L.C., its general partner, By: /s/ Anne Frederick, Managing Director |
01/21/2026 |
|
Carlyle Holdings II GP L.L.C., By: The Carlyle Group Inc., its sole member, By: /s/ Anne Frederick, Corporate Secretary |
01/21/2026 |
|
Carlyle Holdings II L.L.C., By: /s/ Anne Frederick, Managing Director |
01/21/2026 |
|
TC Group Cayman Investment Holdings Sub L.P., By: TC Group Cayman Investment Holdings, L.P., its general partner, By: CG Subsidiary Holdings L.L.C., its general partner, By: /s/ Anne Frederick, Managing Director |
01/21/2026 |
|
TC Group VII, L.L.C., By: TC Group Cayman Investment Holdings Sub L.P., its sole member, By: TC Group Cayman Investment Holdings, L.P., its general partner, By: CG Subsidiary Holdings L.L.C., its general partner, By: /s/ Anne Frederick, Managing Director |
01/21/2026 |
|
TC Group VII, L.P., By: TC Group VII, L.L.C., its general partner, TC Group Cayman Investment Holdings Sub L.P., its GP, TC Group Cayman Investment Holdings, L.P., it GP, CG Subsidiary Holdings L.L.C., its GP, By: /s/ Anne Frederick, Managing Director |
01/21/2026 |
|
** Signature of Reporting Person |
Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v). |
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |